Results 181 to 190 of about 2,072 (218)

Laboratory Evaluation of Spasmodic Dysphonia

Journal of Voice, 2020
To evaluate the utility of comprehensive laboratory evaluation in patients with spasmodic dysphonia (SD).Retrospective chart review.A review of the medical records of 40 patients diagnosed with spasmodic dysphonia from 2009-2018 was preformed to evaluate abnormal test results that were significant when compared with abnormal results of the general ...
Rohan Patel, Sammy Othman, Justin Ross, Robert T. Sataloff, Srihari Daggumati   +4 more
openaire   +3 more sources

Botulinum toxin for spasmodic dysphonia

Physical Medicine and Rehabilitation Clinics of North America, 2003
Botulinum toxin is the accepted method of managing SD and has given most patients with adductor SD the ability to develop satisfactory vocal function. Results have been less satisfactory in abductor SD. Management is accomplished best with a team approach.
Christopher R. Watts, Chad Nye, Renata Whurr   +2 more
openaire   +5 more sources

Treatment Options in Spasmodic Dysphonia

Otolaryngologic Clinics of North America, 1991
Options in the treatment of spasmodic dysphonia include surgical interruption of the recurrent laryngeal nerve, anterior laryngoplasty, voice therapy, and Botulinum toxin injection. Although none of these treatments is ideal, Botulinum toxin injection appears to have the greatest potential to benefit the greatest number of patients.
Robert H. Miller, Gayle E. Woodson
openaire   +3 more sources

Neuropathology of spasmodic dysphonia

The Laryngoscope, 1983
AbstractSpasmodic dysphoria is a devastating voice disorder of unknown etiology, with a variable clinical presentation and response to treatment. Three independent evaluations of brain stem function were performed on spasmodic dysphonic patients, and age and sex‐matched controls.
openaire   +3 more sources

Perceptual Characteristics of Adductor Spasmodic Dysphonia [PDF]

Annals of Otology, Rhinology & Laryngology, 2000
The evaluation of perceptual symptoms is one of the mainstays in the diagnostic workup of adductor spasmodic dysphonia (ADSD). The most widely used perceptual rating system is the GRBAS scale. However, with this system, not all audible features of ADSD can be described. Therefore, we extended the GRBAS system by 6 parameters. The aim of this study was
A. H. Zwinderman, Robert J. Baatenburg de Jong, Ton P. M. Langeveld, Harm A. Drost, Johan H. M. Frijns   +4 more
openaire   +2 more sources

Disfluency in Spasmodic Dysphonia

Journal of Speech, Language, and Hearing Research, 1997
This study examined visual analog scaling (VAS) judgments of disfluency by normal listeners in response to oral reading by speakers with spasmodic dysphonia (SD) and by nondysphonic controls, as well as the variables of frequency of occurrence of disfluencies, speaking rate, number of reading errors, and temporal acoustic measures of interword interval
Christopher R. Watts, Michael P. Cannito, Stephen B. Hood, Annette Renee Burch, Kyla Sherrard, Patrick W. Rappold   +5 more
openaire   +3 more sources

Spasmodic (Laryngeal) Dysphonia

2012
Spasmodic dysphonia (SD) is an adult-onset focal dystonia characterized by abnormal vocal cord contractions activated by speech. There are three forms of spasmodic dysphonia. The commonest form, making up about 90% of cases, is adductor dysphonia in which spasmodic adduction of the vocal cords causes interruptions in phonation called voice breaks ...
Daniel Tarsy, Roongroj Bhidayasiri
openaire   +2 more sources

Botulinum Toxin Treatment for Spasmodic Dysphonia

Acta Oto-Laryngologica, 1993
Effective treatment of adductor type spasmodic dysphonia with botulinum toxin injection is presented. Patients showed objective and/or subjective improvement in phonation. The beneficial effect lasted for approximately 3 months. An immediate complication is temporary hoarseness or aphonia, mainly due to diffusion of BT into the adjacent muscles.
Masanobu Kumada, Hiroko Kosaki, Hajime Hirose, Seiji Niimi, Takeo Kobayashi   +4 more
openaire   +3 more sources

Laryngeal Sensory Symptoms in Spasmodic Dysphonia

Journal of Voice, 2023
The purpose of this research was to determine whether an association between laryngeal hypersensitivity (LH) and spasmodic dysphonia (SD) exists using the LH Questionnaire (LHQ). This study also explored the prevalence of self-reported upper respiratory infection (URI) at the time of SD onset across SD phenotypes.Individuals with and without SD were ...
Victoria Vanderaa, Lisa A. Vinney
openaire   +3 more sources

Contemporary management of spasmodic dysphonia

Current Opinion in Otolaryngology & Head and Neck Surgery, 2004
To review current concept in spasmodic dysphonia management.The standard of care for spasmodic dysphonia in 2004 remains botulinum toxin chemodenervation for symptomatic management. This is supported by a large body of literature attesting to its efficacy in many different hands, particularly for the adductor form of the disorder.
openaire   +3 more sources